US biotech prepares to fight generic biologics.
Reid
Brian
B
D001688:Biological Products / Q000191:economics* / Q000592:standards; D001709:Biotechnology / Q000191:economics* / Q000331:legislation & jurisprudence*; D004274:DNA, Recombinant; D016568:Drugs, Generic / Q000191:economics* / Q000592:standards; D010330:Patents as Topic; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D001688:Biological Products; D004274:DNA, Recombinant; D016568:Drugs, Generic